Cathie Wood Organovo Holdings, Inc. Transaction History

Ark Investment Management LLC

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Jan 24, 2023	SELL	$1.41 - $2.17 $85,396 - $131,426	-60,565 Reduced 22.03%	214,302 $0
Q3 2022 Oct 17, 2022	SELL	$1.76 - $3.55 $29,508 - $59,519	-16,766 Reduced 5.75%	274,867 $563,000
Q2 2022 Jul 11, 2022	SELL	$1.71 - $3.71 $24,752 - $53,702	-14,475 Reduced 4.73%	291,633 $703,000
Q1 2022 Apr 19, 2022	SELL	$2.74 - $4.41 $65,894 - $106,056	-24,049 Reduced 7.28%	306,108 $1.15 Million
Q4 2021 Jan 28, 2022	SELL	$3.63 - $6.86 $186,687 - $352,802	-51,429 Reduced 13.48%	330,157 $1.2 Million
Q3 2021 Nov 12, 2021	SELL	$6.08 - $8.92 $281,181 - $412,523	-46,247 Reduced 10.81%	381,586 $2.6 Million
Q2 2021 Aug 05, 2021	SELL	$6.65 - $9.95 $1.19 Million - $1.77 Million	-178,388 Reduced 29.43%	427,833 $4.02 Million
Q1 2021 May 13, 2021	SELL	$8.67 - $21.7 $6.92 Million - $17.3 Million	-798,399 Reduced 56.84%	606,221 $5.84 Million
Q4 2020 Feb 12, 2021	SELL	$7.19 - $17.05 $127,795 - $303,046	-17,774 Reduced 1.25%	1,404,620 $17.3 Million
Q3 2020 Oct 30, 2020	BUY	$6.27 - $15.8 $8.92 Million - $22.5 Million	1,422,394 New	1,422,394 $11.3 Million

2.44M

17K

Ticker ONVO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 8,712,020
Market Cap $2.96M
Description
Organovo Holdings, Inc., a biotechnology company, focuses on developing 3D tissues that recapitulate key aspects of human disease. Its 3D human tissue platform includes its proprietary NovoGen Bioprinters, which are automated devices that enable the fabrication of 3D living tissues comprised mammalian cells; and related technologies for preparin...

Get notified when there are updates to the investment portfolio of Ark Investment Management LLC, based on Form 13F filings with the SEC.

Stay updated on Ark Investment Management LLC and Cathie Wood with notifications on news.